NCT07408804
- Conditions
- Unresectable Hepatocellular Carcinoma (HCC)
- Locations
-
- Department of Hepatology, Bangladesh Medical University Dhaka, Bangladesh
Clinical trial condition
Unresectable Hepatocellular Carcinoma (HCC)
Explore clinical trials studying Unresectable Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.
8 public trials
3 recruiting studies
Unresectable Hepatocellular Carcinoma (HCC) trial results
NCT07391839
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
- The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
- The First Affiliated Hospital of Jinan University Guangzhou, Guangdong, China
- Zhongda Hospital Nanjing, Jiangsu, China
Recruiting
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
NCT05967143
- Conditions
- Liver Metastases From Colorectal Cancer (mCRC), Unresectable Hepatocellular Carcinoma (HCC)
- Locations
-
- Hôpital Beaujon Clichy, Cedex, France
- Hopital Henri Mondor Créteil, Paris, France
- Hospices Civils de Lyon HCL Centre Hospitalier Lyon-Sud Pierre-Bénite, Rhône, France
- Hospital Universitario Puerta de Hierro - Majadahonda Majadahonda, Madrid, Spain
Not Yet Recruiting
Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC
NCT07596134
- Conditions
- Unresectable Hepatocellular Carcinoma (HCC)
- Locations
-
- Huaihe Hospital of Henan University Kaifeng, Henan, China
- The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang Provinece, China
- The Fourth Affiliated Hospital, Zhejiang University School of Medicine Yiwu, Zhejiang Provinece, China
NCT07314372
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School Nanjing, Jiangsu, China
Not Yet Recruiting
SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma.
NCT06739317
- Conditions
- Unresectable Hepatocellular Carcinoma (HCC)
- Locations
-
- the First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT07368530
- Conditions
- Adenocarcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, +11 more
- Locations
-
- The First Affiiated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT02953743
- Conditions
- Unresectable Hepatocellular Carcinoma (HCC)
- Locations
-
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
- Shanghai Cancer Hospital, Fudan University Shanghai, Shanghai Municipality, China
- Zhongshan Hospital Fudan University Shanghai, Shanghai Municipality, China